1346P Comparison of clinical outcomes of patients with METΔex14 NSCLC treated with first-line capmatinib in the GEOMETRY mono-1 study with those of a cohort of real-world patients

Authors:
  • JNJ.W. Neal
    J.W. Neal
  • AMA.S. Mansfield
    A.S. Mansfield
  • VDV. Doban
    V. Doban
  • HKH. Kanakamedala
    H. Kanakamedala
  • WWW-H. Wu
    W-H. Wu
  • AJA. Joshi
    A. Joshi
  • EJE. de Jong
    E. de Jong
  • MGM. Giovannini
    M. Giovannini
  • CBC.S. Baik
    C.S. Baik

Abstract
No abstract available